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using synthesis and NMR of an ion channel blocker
peptide toxin with multiple diselenide bonds†
Krisztina Fehe´r,‡ab Istva´n Tima´ri,‡a Kinga Ra´kosi,‡c Ja´nos Szoloma´jer,c
Tu¨nde Z. Illye´s,d Adam Bartok,e Zoltan Varga,ef Gyorgy Panyi,eg Ga´bor K. To´th*c
and Katalin E. Ko¨ve´r*a
Anuroctoxin (AnTx), a 35-amino-acid scorpion toxin containing four disulﬁde bridges, is a high aﬃnity blocker of
the voltage-gated potassium channel Kv1.3, but also blocks Kv1.2. To improve potential therapeutic use of the
toxin, we have designed a double substituted analog, [N17A/F32T]-AnTx, which showed comparable Kv1.3
aﬃnity to the wild-type peptide, but also a 2500-fold increase in the selectivity for Kv1.3 over Kv1.2. In the
present study we have achieved the chemical synthesis of a Sec-analog in which all cysteine (Cys) residues
have been replaced by selenocysteine (Sec) forming four diselenide bonds. To the best of our knowledge
this is the ﬁrst time to replace, by chemical synthesis, all disulﬁde bonds with isosteric diselenides in
a peptide/protein. Gratifyingly, the key pharmacological properties of the Sec-[N17A/F32T]-AnTx are retained
since the peptide is functionally active. We also propose here a combined experimental and theoretical
approach including NOE- and 77Se-based NMR supplemented by MD simulations for conformational and
dynamic characterization of the Sec-[N17A/F32T]-AnTx. Using this combined approach allowed us to attain
unequivocal assignment of all four diselenide bonds and supplemental MD simulations allowed
characterization of the conformational dynamics around each disulﬁde/diselenide bridge.Introduction
The disulde pattern of polypeptides containing multiple
disulde bridges is of considerable interest because theemistry, University of Debrecen, Egyetem
over@science.unideb.hu
r Chemistry, Ghent University, Kringslaan
ty of Szeged, Do´m te´r 8, H-6720, Szeged,
.hu
ity of Debrecen, Egyetem te´r 1, H-4032,
, University of Debrecen, Egyetem te´r 1,
nction Research Group, Egyetem te´r 1,
h Group, University of Debrecen, Egyetem
ESI) available: Details of synthesis and
analog of [N17A/F32T]-AnTx mutant
MS spectra, overlay of 1H-13C HSQC
]-AnTx and its Sec-analog, scheme and
e CPMG-HSQMBC pulse sequence and
ssical HMQC method, 1H, 13C, 15N and
17A/F32T]-AnTx peptide. See DOI:
is work.presence of disulde bonds is essential for maintaining the
tertiary structure responsible for the observed biological
activity. Therefore, a key issue in the structural characterization
of these peptides is an unambiguous determination of the
pattern of disulde pairing. Since small, exible disulde-rich
peptides are typically diﬃcult to crystallize, therefore nuclear
magnetic resonance (NMR) spectroscopy and mass spectrom-
etry (MS) are the most commonly used techniques for eluci-
dating their structures.1
MS determination of a disulde bonding pattern is a chal-
lenging task primarily relying on manual interpretation.2,3 It
requires either enzymatic digestion of the protein where disul-
de scrambling may take place, or chemical modication if the
target protein is cysteine rich, or else contains an unexpected
folding pattern with unknown disulde bonds.
NMR provides powerful tools for determining the three-
dimensional structures of these small proteins and peptides,
but, due to the unfavorable NMR properties of sulfur isotopes,
disulde bonds oen present a ‘blind spot’ in NMR structural
investigations.1 Experimental observations supported by DFT
quantum-chemical calculations proved that the redox state of
cysteine residues can be safely disclosed on the basis of Cys 13Cb
chemical shis.4 These data, however, do not provide infor-
mation about the disulde bridge connectivity. Heretofore the
most commonly used approach for determining S–S connec-
tivity relied on the detection of interresidue dipolar (NOE)This journal is © The Royal Society of Chemistry 2016
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View Article Onlineinteractions between the b-methylene protons of the covalently
linked cysteine residues.5 Detection of these weak inter-disul-
de NOE contacts is oen hampered by spin-diﬀusion eﬀects
due to the strong intraresidue cross-relaxation between the
geminal beta protons of Cys and/or in some cases by an
enhanced conformational exibility around the disulde
bonds, leading to an ambiguous assignment of the disulde
network. However, such uncertainties could be resolved by
stereospecic deuterium labeling of the cysteine beta protons at
the cost of laborious isotope labeling. Besides, in the case of
closely packed disulde bonds, the NOE contacts can be also
ambiguous and lead to incorrect pairing of Cys residues.
Alternatively, as has been recently suggested, replacement of
the NMR-inactive 32S nucleus by 77Se possessing more favorable
magnetic properties6,7 – by mutation of cysteine into seleno-
cysteine (Sec) residues8–13 – may allow the detection of dis-
elenide pairing directly through the three-bond 3J(1H, 77Se)
couplings across the diselenide bond.5 Importantly, it was also
conrmed that the isosteric replacement of the disulde bond
with diselenide has no signicant eﬀect, in general, on the
three-dimensional structure and the associated biological
activity of peptides.14 In addition, using 77Se NMR both
the conformational and dynamic properties of diselenide
(disulde) bonds can be explored.
The Sec residues can be introduced into peptides or proteins
either by chemical synthesis11,12,14–16 or by recombinant expres-
sion.7,9,10,17Using chemical synthesis, substitution of only one or
two disulde bridges has been reported in most cases whereas
multiple disulde bonds can be replaced with diselenides by
applying recombinant expression. Recently, an increasing
interest also has emerged for the synthesis of selenium-con-
taining polymers due to their potential applicability as
biomaterials.18,19Biological background
Peptide toxins form an important class of disulde bond con-
taining peptides and proteins. One particular group of peptide
toxins isolated from scorpions and other venomous animals
targets Kv1.3, the voltage-gated ion channel of human T
lymphocytes.20 The Kv1.3 channel plays a crucial role in antigen-
induced activation and proliferation of human T cells in
general, and in those of eﬀector memory T cells in particular.21
These latter cells are responsible for tissue damage in certain
autoimmune diseases such as multiple sclerosis, type I dia-
betes, and rheumatoid arthritis.22 High aﬃnity and selectivity
Kv1.3 inhibitors persistently inhibit the proliferation of eﬀector
memory T cells thereby ameliorating the symptoms of the
disease in animal models. This indicates the great therapeutic
value of the Kv1.3 inhibitors.22–24
Anuroctoxin (AnTx), a 35-amino-acid scorpion toxin having
four disulde bridges, is a high aﬃnity blocker of Kv1.3
channel, but also blocks Kv1.2.25 Improving selectivity of the
toxin for Kv1.3 over Kv1.2 while keeping the high aﬃnity for
Kv1.3 opens the door to the toxin's therapeutic use. In line with
these, we have constructed a double substituted analog of AnTx,
[N17A/F32T]-AnTx, which is characterized by comparable Kv1.3This journal is © The Royal Society of Chemistry 2016aﬃnity to the wild-type peptide but shows a 2500-fold increase
in the selectivity for Kv1.3 over Kv1.2 and other ion channels
tested (Kv1.1 and KCa3.1).26 Thus, [N17A/F32T]-AnTx may serve
as an excellent template for a novel therapeutically applicable
peptide, and, interestingly, understanding the structural
features of this peptide may lead to a better understanding of
the nature of the selectivity of scorpion toxins between Kv1.3
and Kv1.2.
In the present work we report the chemical synthesis of a Sec-
analog of [N17A/F32T]-AnTx during which – for the rst time to
our knowledge – the replacement of all four disulde bonds
with isosteric diselenide bonds has been achieved. Using
a combined NOE- and 77Se NMR-based approach unequivocal
assignment of the diselenide (disulde)-bond connectivities
was also accomplished. Moreover, the signicant broadening of
some of the 77Se resonances revealed the presence of slow
conformational exchange processes which have been subse-
quently interpreted by molecular dynamics (MD) simulations.
Results and discussion
Synthesis of the Sec-analog of [N17A/F32T]-AnTx mutant
For the preparation of the anuroctoxin derived peptides, both
the Boc and Fmoc chemistry were used previously with
success.26 Since the stability of several Boc compatible Se pro-
tecting groups is signicantly lower than the corresponding
sulfur protecting groups (e.g., BnSe is a much better leaving
group than the corresponding sulfur derivative12,27), for the
solid-phase synthesis of selenocysteine analog of [N17A/F32T]-
AnTx mutant, the Fmoc/tBu strategy was applied. Correspond-
ingly, the related Na-Fmoc derivative of the 4-methoxy-benzyl
protected selenocysteine8 was synthesized and used as
replacement for all eight cysteines in the original sequence. For
the linear Sec(Mob) protected [N17A/F32T]-AnTx analog,
a standard synthetic protocol was applied with DCC/HOBt
(1 : 1) as coupling agent in a 3-fold molar excess. The removal of
the Mob group from the selenocysteine residues can be carried
out, according to previous studies, under various conditions,
e.g., acidic treatment, I2, or applying a sub-stoichiometric
amount of 2,20-dithiobis(5-nitropyridine). With regard to the
complexity of the amino acid sequence of the peptide, we
decided to achieve the cleavage from the resin together with the
protecting groups commonly used in Fmoc/tBu synthesis and
removal of the Mob group from the selenocysteine side-chains
in a two-step protocol. Acidolytic cleavage of the Sec(Mob)
peptide from the resin was performed under various conditions
(TFA/H2O/TIS cocktail in 93/5/2, v/v, at low temperature for 2 h;
TFA/H2O/TIS cocktail in 93/5/2, v/v at room temperature for 2.5
h) and in both cases the crude product obtained consisted
mainly of the compound with all eight Mob groups intact
besides compounds which had partially removed one, two, or
even three Mob groups. In order to avoid incomplete removal of
the side-chain protecting groups, and considering the fact that
it follows Mob group de-protection, we decided to carry on with
this complex reaction mixture. For Mob de-protection/cycliza-
tion we tried procedures well established in cysteine chem-
istry,27,28 like the DMSO/TFA (v/v) procedure (10% DMSO/TFAChem. Sci., 2016, 7, 2666–2673 | 2667
Fig. 1 Eﬀect of AnTx variants on Kv1.3 channel. Whole-cell Kv1.3
current traces were measured in activated human lymphocytes in
whole cell conﬁguration. Cells were held at100mV then depolarized
to +50 mV for 15 ms every 15 s. The bath was perfused continuously.
(A), The traces show the K+ current before the application of the toxin
(control), after the equilibration of the block in the presence of 3 nM
Sec-[N17A/F32T]-AnTx (as indicated) and after recovery from block
during the perfusion of the bath with toxin-free solution (wash). (B),
The blocking eﬀect was fully reversible. Peak K+ currents were
determined and plotted as a function of time. Grey bars mark the
presence of 3 nM Sec-[N17A/F32T]-AnTx in the bath solution. Other
experimental details are as in A. (C), The traces show the K+ current
before the application of the toxin (control), after the equilibration of
the block in the presence of 3 nM [N17A/F32T]-AnTx (as indicated) and
after recovery from block during the perfusion of the bath with toxin-
free solution (wash). (D), Concentration-dependence of K+ current
block by Sec-[N17A/F32T]-AnTx. The remaining fraction of the Kv1.3
current was calculated as I/I0, where I0 and I are the peak K
+ currents
measured in the control solution and upon reaching equilibrium block
during bath perfusion with the test solution containing the toxin at
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View Article Onlineand 4% DMSO/TFA) and the I2-mediated method (added
quantitatively or in excess), but in all cases we obtained a very
complex mixture of compounds from which the desired dis-
elenide-bridged peptide could not be isolated. Cleavage of the
p-methoxybenzyl group and intramolecular oxidation to the
diselenide peptide was successfully achieved with the more
gentle 2,20-dithiobis(5-nitropyridine) (DTNP) in TFA. Incubation
of the protected Sec-containing peptide in TFA with DTNP
resulted in eﬀective protecting group removal and its substitu-
tion by the 2-(5-nitropyridyl) (Npys) group derived from DTNP
fragmentation, independent of the number of DTNP equiva-
lents and peptide concentration used. Aer test reactions,
a nal 4 mM peptide concentration in TFA was used with 1
equiv. DTNP incubation for 1 h. The reaction was quenched via
precipitation into cold diethyl ether and, aer isolation of the
precipitate, the crude material was treated with one equivalent
of L-cysteine in pH 8 NH4OAc buﬀer solution in order to induce
collapse into the desired multiple diselenide-peptide. HPLC
analysis of the resulting solution showed an almost instanta-
neous transformation of the hemi-reduced intermediate into
the multiple diselenide compound (Scheme 1).
The HPLC trace of the folded, puried tetra diselenide toxin
analog is shown on Fig. S1.† The spectra of mass spectrometric
analyses of the multiple selenocysteine peptide recorded with
quadrupole ESI and Q-TOF spectrometers are depicted in
Fig. S2–S5.† The characteristic isotopic selenium abundance
(Fig. S5†) is more complicated than the sulfur containing ones,
but a careful study led to the justication of the correct
molecular ion (Fig. S4†). Subsequent NMR studies and biolog-
ical measurements of the isolated main product proved that all
four diselenide bridges are completely analogous with the
disulde connectivities from the native [N17A/F32T]-AnTx
peptide.indicated concentrations, respectively. The voltage protocol and other
experimental conditions were the same as in (A). The superimposed
solid line is the Hill equations ﬁtted to the data points (see Experi-
mental). The best ﬁt yielded IC50 ¼ 1.54 nM, and H ¼ 0.93. Error bars
indicate SEM (n ¼ 3–5). The dashed line shows the dose–response
relationship of [N17A/F32T]-AnTx which is characterized by IC50 ¼
0.63 nM and H ¼ 0.88 (data from ref. 26).The Sec-analog of [N17A/F32T]-AnTx retains its biological
activity
Prior to obtaining detailed structural information one key
question remained to be answered, namely, whether the Sec-
analog of [N17A/F32T]-AnTx still blocks the Kv1.3 channel with
high aﬃnity. To this end, the Sec-analog was tested on Kv1.3
expressed in human peripheral blood lymphocytes. Fig. 1 shows
that the peptide in 3 nM concentration blocks approx. 75% of
the peak current (Fig. 1A), which is comparable to the inhibition
of Kv1.3 with the double mutated peptide [N17A/F32T]-AnTx at
identical concentration (89% inhibition in the latter case,26
Fig. 1C). Fig. 1B shows that the block of Kv1.3 develops quickly
and it is rapidly reversible by perfusing the bath with toxin-free
solution. The dose–response relationship obtained for Kv1.3
inhibition by Sec-[N17A/F32T]-AnTx (Fig. 1D) indicates an IC50Scheme 1 Amino acid sequence of Sec-[N17A/F32T]-AnTx with four
diselenide bonds.
2668 | Chem. Sci., 2016, 7, 2666–2673of 1.54 nM, which is comparable to that of [N17A/F32T]-AnTx
(IC50 ¼ 0.63 nM, dashed line). The Hill coeﬃcient was close to 1
for both peptides (H ¼ 0.93 for Sec-[N17A/F32T]-AnTx and H ¼
0.88 for [N17A/F32T]-AnTx) which argues that the pepti-
de:channel stoichiometry of inhibition is 1 : 1, as predicted by
currently accepted models of toxin binding to the channels.29
In summary, the key pharmacological property of [N17A/
F32T]-AnTx, i.e., the high aﬃnity block of the Kv1.3 current, is
retained in Sec-[N17A/F32T]-AnTx so the peptide is functionally
active.NMR investigation of the Sec-analog of [N17A/F32T]-AnTx
Almost complete assignments of 1H, 13C and 15N resonances of
Sec-mutant have been achieved using standard solution state
NMR techniques. The 1H resonances were assigned basedThis journal is © The Royal Society of Chemistry 2016
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View Article Onlineon two-dimensional (2D) homonuclear correlation spectra
including 1H-1H COSY, TOCSY and NOESY. Whereas the well-
resolved cross peaks of 1H-13C and 1H-15N HSQC spectra
allowed the assignment of 13C and 15N resonances (see Table S1
in the ESI†), it should be mentioned that some of the Hb–Cb
cross peaks, such as of Sec4, Sec10 and Sec24 residues, are
signicantly broadened and have, therefore, lower intensities in
the 1H-13C HSQC correlation map (Fig. 2); this is indicative of
slow conformational dynamics occurring in the vicinity of those
residues. Note that similar exchange mediated line-broadening
was observed in the 1H-15N HSQC spectrum for T5, Q8, H9, U10,
T11 and K30 residues (data not shown). It was also found that
the Sec-derivative possesses almost identical 1H, 13C, and 15N
chemical shis as the S-containing peptide (selected regions of
1H-13C HSQC spectra of the two peptide analogs are shown in
Fig. S6†), suggesting high similarity of their three-dimensional
structures.
The oxidized state of all eight Sec residues incorporated into
the peptide could be unequivocally proved on the basis of the
characteristic Hb/Cb and Se chemical shis of the Sec residues
(Table S1†). The MS data also supported the formation of four
intramolecular diselenide bonds.
To establish the location of bridged residues, 1H-1H 2D
NOESY spectra were recorded with 150 ms and 300 ms mixing.
However, even using longer mixing time (300 ms), NOE cross
peaks between the b-methylene protons of the covalently linked
Sec residues could be hardly detected. This may be due partly to
the strong intraresidue cross-relaxation between the geminal
b-protons of Sec, partly to the line broadening caused by slow
conformational dynamics around the Se–Se bridge, and also to
the severe signal overlap in the region of interest. Specically,
inspection of the NOESY spectrum shown in Fig. 3 reveals only
one Se–Se bond unequivocally, which can be assigned to the
Sec4–Sec24 bridge. Unambiguous assignment of the other inter-
Sec(Hb) cross peaks is hampered by the strong signal overlap.
To take advantage of our ‘Se NMR-spies’ incorporated into
the peptide sequence, multiple bond 1H-77Se correlation spectraFig. 2 The Hb/Cb region of
1H-13C HSQC spectrum of Sec-[N17A/
F32T]-AnTx. Broadened (lower intensity) Hb–Cb cross peaks of Sec4,
Sec10 and Sec24 residues are indicated by blue asterisks. Hb–Cb cross
peaks of the remaining Sec residues are labelled by red asterisks.
This journal is © The Royal Society of Chemistry 2016were recorded using standard HMQC or HMBC experiments.
Sites around disulde/diselenide bridges in peptides/proteins,
however, are oen regions of conformational exchange. The
exchange process, in general, can be detrimental to the quality
of NMR spectra, resulting in broad and very weak, or even
unobservable signals, and which may be detrimental to struc-
ture elucidation and, in particular, to the NMR-based charac-
terization and assignment of disulde/diselenide bonds. To our
disappointment, even aer several attempts using a diﬀerent
experimental setup (see ESI† for details and selected examples),
only a few and exclusively intraresidue 1H-77Se correlations
could be observed, probably due to conformational exchange
line broadening.
To improve the sensitivity of 1H-77Se multiple bond correlation
measurements, a modied, 77Se-decoupled variant of the CPMG-
HSQMBC experiment30–32 has been developed in our group. This
experiment considerably reduces the adverse line broadening
eﬀect of conformational exchange and also eﬃciently suppresses
the undesired co-evolution of proton–proton couplings (such as
the large geminal coupling between the Hb protons of Sec) during
the long scalar coupling evolution period matched to the intra-
and interresidue multiple bond 1H-77Se couplings. To minimize
heating of the probe electronics and the sample during the long
duration of CPMG pulse train, low-power composite 180 pulses
were applied on both the proton and Se nuclei. Note that, simi-
larly, CPMG pulse trains have been successfully employed in
HSQC experiments to reduce the undesired eﬀect of exchange
processes and, as a consequence, for better observation of
exchange broadened signals in nucleic acids and proteins.33–35
The details of the experiment proposed here (scheme in
Fig. S7† and Bruker code of the pulse sequence are given in ESI†)
and comparison of its performance to the classical HMQC/HMBC
methods are demonstrated in the ESI (Fig. S8–S10†). Recording
several 1H-77Se CPMG-HSQMBC spectra with the sequence ofFig. 3 Partial contour plot of 1H-1H NOESY spectrum (500 MHz, sm ¼
300 ms) of Sec-[N17A/F32T]-AnTx. NOE cross peaks between the b-
methylene protons of covalently linked Sec residues are indicated by
arrows.
Chem. Sci., 2016, 7, 2666–2673 | 2669
Fig. 5 Development of torsion angles along the trajectory for disulﬁde
bridges 4–24, 10-29, 14–31 and 19–34. The ﬁrst row (a) shows the c3
angle is the torsion angle around the disulﬁde bond (as deﬁned by atoms
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View Article OnlineFig. S7† at diﬀerent temperatures and using evolution times
matched to diﬀerent long-range couplings, we found that the
largest number of connectivities could be detected at 318 K with
the coupling evolution time set to 30–35 ms. The resulting spec-
trum shown in Fig. 4 allowed unambiguous assignment of all
eight Se-resonances (as given on the projection at le), though
some of the correlations are weak due to exchange broadening as
noticed. Nevertheless, the cross peaks enlarged and shown in
insets at lower intensity threshold could be assigned to provide
direct evidence of two additional Se–Se pairings, between Sec14–
Sec31 and Sec19–Sec34 residues, respectively.
Since the chemical shis (Cb, Se) of Sec-s already conrmed
that all eight Sec residues are involved in diselenide bonds, thus
the remaining, unassigned Se–Se connectivity could be unam-
biguously assigned to the Sec10 and Sec29 residues.CBN-SGN-SGC-CBC). The c2 sidechain torsion angle is shown for (b) the
N terminal (as deﬁned by atoms CAN-CBN-SGN-SGC) and (c) the C
terminal residue (as deﬁned by atoms SGN-SGC-CBC-CAC) of the
cysteine pair in the bridge.Molecular dynamics (MD) simulation
MD calculations were found to be useful tools to analyze
disulde bridge connectivities in small disulde-rich
proteins.36,37 In order to nd an explanation for the observed
NMR behaviour of peptide sites around diselenide bridges, we
carried out a 100 ns molecular dynamics (MD) simulation on
the [N17A/F32T]-AnTx peptide. Since replacement of disulde
bridges with diselenide bonds has been demonstrated to be
bioisoteric due to high similarity between the conformational
properties of sulfur and selenium,11 the simulations were
carried out on the disulde bridge containing peptide. The c3
angle has taken up conformations around the canonical 90
and has mostly persisted in the conformation presented in the
starting structure shown in Fig. 5a. The dynamic behavior of the
diﬀerent S–S bridges in the trajectory could be classied into
three groups according to the conformation along the side
chain c2 dihedral angles of the cysteine residues (Fig. 5b and c):
the conformation around the 14–31 bridge was static apart fromFig. 4 1H-77Se multiple bond correlation spectrum of Sec-[N17A/
F32T]-AnTx collected with a refocused 77Se-decoupled CPMG-
HSQMBC experiment at 318 K and natural abundance of 77Se isotope.
Heteronuclear coupling evolution time was set to 33 ms. Assignment
of 77Se resonances are given on the projection at left side. Interresidue
1H-77Se cross peaks detected are shown in insets at lower intensity
threshold and provide direct evidence of Se–Se bridges between
Sec14–Sec31 and Sec19–Sec34 residues, respectively.
2670 | Chem. Sci., 2016, 7, 2666–2673small uctuations, the 19–34 bridge was most dynamic with
frequent transitions between diﬀerent states, and the bridges
10–29 and 4–24 showed intermediate dynamic behavior with
less frequent or a single transition between conformations.
Thus, the strong intra/inter-residue HSQMBC correlations for
77Se resonances in bridge 14–31 are due to the lack of any
exchange process for the nuclei involved, while the nuclei in
bridge 19–34 may experience fast exchange line narrowing. The
weaker correlations for the connectivities in bridges 10–29 and
4–24 could be attributed to the presence of intermediate
conformational exchange broadening.Conclusions
In summary, a Sec-analog of the biologically active [N17A/F32T]-
AnTx peptide toxin containing four diselenide bonds has been
produced with chemical synthesis. To the best of our knowledge,
this is the rst time all disulde bonds in a protein were replaced
by chemical synthesis with isosteric diselenides. We found that
the Sec-derivative displayed similar voltage-gated potassium
channel (Kv1.3) blocking potency and almost identical 1H, 13C
and 15N chemical shis as the S-containing peptide, suggesting
high similarity of their three-dimensional structures including
their Se–Se/S–S bridge pattern, respectively.
Using a combined NMR approach relying on characteristic
chemical shis, 1H-1H NOEs and 1H-77Se multiple bond
connectivities, the diselenide network of the Sec-analog was
unequivocally disclosed. To improve the sensitivity of 1H-77Se
correlation NMR experiment for peptides with multiple dis-
elenide bonds and in the presence of exchange broadening,
a modied CPMG-HSQMBC pulse sequence was designed and
applied. The CPMG-cycles employed eﬃciently reduce the loss
of spin coherence due to both chemical exchange and unde-
sired evolution of proton–proton couplings.
Finally, NMR experiments complemented with MD simula-
tions allowed us to explore and characterize the conformational
dynamics of diselenide/disulde bonds.This journal is © The Royal Society of Chemistry 2016
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Electrophysiology
Cells. Kv1.3 currents were measured on human peripheral
lymphocytes obtained from healthy volunteers. Mononuclear
cells were isolated using the Ficoll-Hypaque density gradient
separation technique and cultured in 24-well culture plates at
37 C in a 5% CO2 incubator in RPMI 1640 medium supple-
mented with 10% fetal calf serum (Sigma-Aldrich), 100 mg mL1
penicillin, 100 mg mL1 streptomycin, and 2 mM L-glutamine
(density, 5  105 cells per mL) for 2 to 5 days. To increase K+
channel expression 5, 7.5, or 10 mg mL1 phytohemagglutinin A
(Sigma-Aldrich) was added to the medium.
Electrophysiology. Electrophysiological recordings were
carried out with the patch-clamp technique in the voltage-
clamp mode in whole cell conguration. For the recordings an
Axon Axopatch 200B amplier and Axon Digidata 1440 digital
interface were used (Molecular Devices, Sunnyvale, CA).
Micropipettes were pulled from GC 150 F-15 borosilicate
capillaries (Harvard Apparatus Kent, UK) resulting in 3 to
5 MU resistance in the bath solution, which consisted of
145 mM NaCl, 5 mM KCl, 1 mMMgCl2, 2.5 mM CaCl2, 5.5 mM
glucose, 10 mM HEPES, pH 7.35, 302–308 mOsM L1. The
pipette lling solution contained 140 mM KF, 2 mM MgCl2,
1 mM CaCl2, 10 mM HEPES and 11 mM EGTA, pH 7.22,
295 mOsM L1.
Kv1.3 currents were elicited by 15 ms long depolarization
impulses to +50 mV from a holding potential of 100 mV every
15 s. To acquire and analyze the measured data a pClamp10
soware package was used. Current traces were lowpass-ltered
by the analog four-pole Bessel lters of the ampliers. The eﬀect
of the toxin in a given concentration was determined as
remaining current fraction (RF ¼ I/I0, where I0 is the peak
current in the absence of the toxin and I is the peak current at
equilibrium block at a given toxin concentration). Points on the
dose–response curves represent the mean of 5 independent
measurements where the error bars represent the S.E.M. Data
points were tted with a two-parameter Hill equation, RF ¼
IC50
H/(IC50
H + [Tx]H), where IC50 is the dissociation constant, H
is the Hill coeﬃcient and [Tx] is the toxin concentration.NMR spectroscopy
3.9 mg peptide toxin was dissolved in 280 mL buﬀer (90 : 10 H2O/
D2O, 10 mM Na3PO4, pH 5.7, 50 mM NaCl, 1 mM NaN3) for all
NMR runs whereas 7.9 mg was disssolved in D2O buﬀer for
77Se
NMR measurements and transferred into a Shigemi NMR tube.
All NMR spectra were recorded on an Avance II 500 (Bruker,
Rheinstetten, Germany) spectrometer at 303 K, if not indicated
otherwise. 1H chemical shis are referenced to sodium 2,2-
dimethyl-2-silapentane-5-sulfonate (0 ppm), while heteronuclear
shis are referenced indirectly based on the gyromagnetic ratios
for 13C, 15N, and 77Se, respectively. All heteronuclear correlation
spectra (1H-13C and 1H-15N HSQC, selenium-decoupled 1H-77Se
CPMG-HSQMBC, HMBC and HMQC) were acquired at natural
abundance. The 1H-77Se multiple bond correlation spectra were
recorded at 283, 303, 313, and 318 K, respectively using scalarThis journal is © The Royal Society of Chemistry 2016coupling evolution timematched to 10, 12, 15, 17, 20, and 30 Hz,
typically in overnight experiments. 2D 1H-1H NOESY spectra
using aWatergate sequence for water suppression were recorded
with 150 and 300 ms mixing, respectively. TOCSYmixing was set
to 80 ms. The 1H, 13C, 15N, and 77Se 90 hard pulses were of 11.5,
13.0, 29.0, and 15.0 ms duration, respectively.Computational methods
All MD simulations were performed using AMBER version
12.38 The AMBER ﬀ99SB force eld39 for the peptides and
the TIP3P model40 for water were used. The cut-oﬀ used for
non-bonded interactions was 8 A˚. The particle-mesh Ewald41
procedure was used to describe long-range electrostatic
interactions with a maximal grid spacing of 1 A˚. Periodic
boundary conditions were applied with a truncated octahe-
dron geometry. The SHAKE42 algorithm was used to keep the
bond lengths of hydrogen atoms rigid allowing a timestep of
2 fs to be used.
Since there is no selenium atom type implemented in the
chosen force eld, we used sulfur in place of selenium.
Comparison of the properties of sulfur and selenium shows that
the structure and dynamics of the selenium-containing peptide
should be very similar to the sulfur-containing one. This
assumption was conrmed by comparison of the 1H, 13C, and
15N chemical shis, which were strongly correlated.
Protocol. First minimization in 10 000 steps was performed
to remove bad contacts switching from steepest descent to
a conjugate gradient algorithm aer 100 steps. Aer minimi-
zation at a constant pressure MD was carried out to equilibrate
the system for 0.5 ns, during which the density stabilized at
around 0.9965 g cm3, and the temperature settled at ca. 300 K.
Subsequently, a classical constant total energy MD producing
micro canonical NVE ensemble was carried out for 100 ns.
All simulations were run in a single Nvidia GTX680 GPU
using the GPU43,44 implementation of the pmemd provided in
the AMBER12 simulation package. Using the described proto-
cols a 100 ns-long calculation of the peptide took about 25 h to
complete.
Analysis. Translational centre of mass motions were
removed every 1000 steps for NVE simulations. 50 000 coordi-
nate snapshots were saved for analysis in all cases. The trajec-
tories were analyzed with ptraj45 and visualized in VMD.46
The stability of the trajectories were analyzed using the
mdout_analyser.py.Acknowledgements
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